In patients with moderate-to-severe allergic rhinoconjunctivitis induced by house dust mites, subcutaneous allergen immunotherapy is effective and generally well tolerated.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/subcutaneous-allergen-immunotherapy-shows-promise-moderate-2025a1000pwb?src=rss
Author :
Publish date : 2025-09-26 18:57:00
Copyright for syndicated content belongs to the linked Source.
